Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3 USD | +5.26% | +5.26% | +15.38% |
2022 | PharmChem, Inc.'s Equity Buyback announced on May 2, 2022, has cancelled. | CI |
2022 | PharmChem, Inc. announces an Equity Buyback for $5 million worth of its shares. | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Screening
70.1
%
| 4 | 67.2 % | 4 | 70.1 % | +7.36% |
Sweat Patch
29.9
%
| 2 | 32.8 % | 2 | 29.9 % | -5.96% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 6 | 100.0 % | 6 | 100.0 % | +3.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thompson Clark
CEO | Chief Executive Officer | - | - |
Shana Veale
DFI | Director of Finance/CFO | - | 01/17/01 |
Douglas Crook
COO | Chief Operating Officer | - | 01/97/01 |
Sales & Marketing | - | - | |
Kerri Wagner
PRN | Corporate Officer/Principal | - | 01/15/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thompson Clark
CEO | Chief Executive Officer | - | - |
Tim Eriksen
CHM | Chairman | 55 | 31/21/31 |
James Ford
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,767,331 | 4,601,254 ( 96.52 %) | 119,600 ( 2.509 %) | 96.52 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+15.38% | 13.94M | |
-25.06% | 7.76B | |
+67.56% | 4.35B | |
+2.59% | 2.67B | |
-2.45% | 2.64B | |
-47.56% | 2.1B | |
-17.86% | 1.73B | |
-19.62% | 1.52B | |
+12.59% | 1.18B | |
-45.36% | 1.11B |
- Stock Market
- Equities
- PCHM Stock
- Company PharmChem, Inc.